Summary:
- The article discusses the importance of studying rare diseases, which affect a small percentage of the population but can have a significant impact on those affected.
- It highlights the challenges in researching and developing treatments for rare diseases, such as the lack of financial incentives for pharmaceutical companies and the difficulty in conducting clinical trials with small patient populations.
- The article suggests that by 2025, the study of rare diseases will become more prevalent, as advancements in technology and a growing understanding of genetic factors contribute to better diagnosis and treatment options for these conditions.